Brickroad
Brickroad
IndexSignalsBlog

Product

  • Information Frontier Agent
  • Vendor Management Agent
  • Product tour
  • Pricing

Solutions

  • Utility estimation
  • Context assembly
  • Market intelligence

Suppliers

  • Sell your data
  • Start onboarding
  • Programmatic Data License

Community

  • Public index
  • Signals
  • Blog

Company

  • About
  • Team
  • Careers
  • Brand

Connect

  • LinkedIn
  • X
PrivacyTermsCookies

© 2026 Brickroad

/ Index / ClarityStorm / Reconciled, versioned snapshot of the FDA adverse-event

Reconciled, versioned snapshot of the FDA adverse-event

ClarityStormclaritystorm.com Health CareAlternativeReferenceUSUK

Reconciled, versioned snapshot of the FDA adverse-event (FAERS) quarterly extracts: the four 2023 quarterly releases merged into one internally consistent cohort — keeping the maximum observed case version per case, applying the deletion lists those releases supplied, and purging child rows belonging to superseded reports — delivered as seven relational tables (case demographics plus drug, indication, therapy, reaction, outcome and death tables) with documented join semantics

Format
Tabular files
Are you ClarityStorm?Manage this listing
OverviewSampleAt a glanceInventory and coverageSupplier
SampleSign in to see the sample, or to ask for one.Sign in

At a glance

From the index
Sector
Health Care
Data
AlternativeReference
Industry
PharmaceuticalsApplication Software
Themes
AlternativeReference
Instruments
Equities
Coverage
USUK
Procurement
MEDIUM — a published commercial licence page and a live checkout mean a licence conversation is straightforward and a reachable individual answers support; held back from HIGH because the underlying records are free public agency data, the vendor has stopped selling ongoing subscriptions (so a continuously-refreshed licence may not be on offer at all), and a sample is already distributed openly, which limits scarcity and exclusivity

Inventory and coverage

Coverage

Equities in US, UK. Related tickers LLY, NVO, PFE, MRK, ABBV, AMGN, GSK.L.

Format

Tabular files — CSV and Parquet, delivered as a one-time downloadable package with a published per-table schema (field names and types, e.g. 31 fields on the case/demographics table, 23 on the drug table) and a 1,000-row sample; bought through a one-time payment link, not an API or a live feed

Volume

1,541,888 case rows across seven related tables, including roughly 6.38M rows on the drug table; reconciliation removed 2,819,928 child rows belonging to superseded reports and the applied deletion lists excluded 3,103 previously retained cases; 623 repeated drug groups (636 additional rows) deliberately preserved

Structure

Free labels generated by the reconciliation mechanic: retained-versus-superseded case-version resolution (which iteration of a case is authoritative), deletion-list resolution marking cases withdrawn by the agency, case-and-quarter linkage keys that make child rows traceable to a surviving parent, drug role codes (suspect versus concomitant) with drug-group identity, reporter and manufacturer-source attribution, seriousness and outcome coding, and a preserved missingness pattern that itself tells a buyer which fields are unusable rather than silently imputing them

Supplier

ClarityStormclaritystorm.com

ClarityStorm — Reconciled, versioned snapshot of the FDA adverse-event (FAERS) quarterly extracts: the four 2023 quarterly releases merged into one internally consistent cohort — keeping the maximum observed case version per case, applying the deletion lists those releases supplied, and purging child rows belonging to superseded reports — delivered as seven relational tables (case demographics plus drug, indication, therapy, reaction, outcome and death tables) with documented join semantics. Small, precise, single-analyst scale: a 1.5M-case reconciled cohort with published schemas and honest,…

Supplier page

Not yet on file: Sample · Data dictionary · Data frequency · Reporting lag · Point-in-time · License

On this page
  • Overview
  • Sample
  • At a glance
  • Inventory and coverage
  • Supplier